Alvesco Articles

FDA accepts ciclesonide NDA from Nycomed partner Sunovion

7 June 2011

Nycomed licenses US rights to ciclesonide drugs to Sepracor in deal worth up to $430M

4 February 2008

Nycomed's Alvesco gets FDA OK for asthma

28 January 2008

Altana Pharma's 3rd-qtr 2006 sales rise 11%

13 November 2006

Altana's shares rise 3% on news of the sale of its drugs unit to Nycomed for $5.7B

2 October 2006

Altana's EPS rises 11% in the first half of 2006

7 August 2006

Altana's income rises 28% in first-quarter 2006

8 May 2006

Altana in talks to sell pharma unit

8 May 2006

Altana sees net income reach 438M euros in 2005

27 March 2006

Altana's Alvesco gets EU indication extension

27 February 2006

Sanofi-Aventis' obesity drug Acomplia delayed by an FDA "approvable" letter

27 February 2006

Altana's results in line with expectations

6 February 2006

Altana to split Pharma and Chemie

15 August 2005

Australian PBS adds 45 drugs, widens use for 28

8 August 2005

Alvesco does not affect short-term growth, study finds

30 May 2005

Modest 1st-qtr growth for Altana

9 May 2005

Good new data for Altana's Alvesco asthma

28 March 2005

2004 sees a decline in number of NME first launches, with 23 vs 27 in 2003

31 January 2005

First launch of Altana's Alvesco in Europe

24 January 2005

Stock Commentary - Europe

24 January 2005

Stock Commentary - Europe

8 November 2004

Approvable letter for Altana's Alvesco

1 November 2004

Altana AG set for 2004 pretax profit of 600 million euros

4 October 2004

Mexico and Brazil OK Altana's Alvesco

20 September 2004

Once/day Alvesco vs twice/day fluticasone

13 September 2004

Altana beats forecasts with 7% profit rise

9 August 2004

US specialty Rx bill up 26% in 2003, driven by arthritis, cancer therapies, says Medco

31 May 2004

Altana Pharma posts flat sales for 1st-qtr

10 May 2004

Altana's Alvesco cleared in UK

26 April 2004

Aventis' Alvesco shows promise

29 March 2004

UPDATE: Altana Pharma's organic sales growth up 15%, thanks to the

29 March 2004

Australia first to OK Altana's Alvesco-R

8 March 2004

Aventis highlights its late-stage pipeline to justify its stand-alone strategy

16 February 2004

Aventis sells pharma plant to Famar

19 January 2004

Aventis files for US approval of Alvesco

5 January 2004

Near-term risks versus long-term upside at Germany's Altana assessed by MS

22 December 2003

Altana on track as field force spend increases

11 August 2003

US sales boost 1st-qtr profits at Altana

12 May 2003

2002 profits up 27% at Altana on strong sales

24 March 2003

Aventis updates on near-term pipeline

10 February 2003

Showing 1-40 of 40 articles

Go to beginningPrevious
  • 1
NextGo to end